Survanta

Product manufactured by Abbvie Inc.

Application Nr Approved Date Route Status External Links
BLA020032 None Endotracheal None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Survanta Is Indicated For Prevention And Treatment (“rescue”) Of Respiratory Distress Syndrome (Rds) (Hyaline Membrane Disease) In Premature Infants. Survanta Significantly Reduces The Incidence Of Rds, Mortality Due To Rds And Air Leak Complications.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Beractant

Comments